fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd

Updated on October 19, 2020

Stock/Share Code - SUNPHARMA

Sun Pharmaceuticals Industries is in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

Below is the details of SUNPHARMA Sun Pharmaceuticals Industries Ltd

Market Cap₹124,825 Cr.
Current Price ₹484.5 as on 23 Oct 20
52 Week High / Low Price₹564.9 / ₹312
Face Value₹1
Stock P/E41.89
Book Value₹101.68
Dividend Yield0.77 %
ROCE11.42 %
ROE12.73 %
Sales Growth (3yrs)17.71 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has delivered good profit growth of 31.47% CAGR over last 5 years Company has been maintaining a healthy dividend payout of 89.23%
Cons: Stock is trading at 5.10 times its book value Tax rate seems low Company has a low return on equity of 8.82% for last 3 years. Earnings include an other income of Rs.1513.53 Cr. Company has high debtors of 179.65 days.

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹171.25 41.89 ₹124,825.4 Cr. 0.77 ₹531.95 Cr. -30.32 -10.46 2963.04 11.42
2. Dr Reddy's Labs ₹5,018.25 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹757.55 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹782.8 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹417.2 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹52.65 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹424.3 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Alkem Lab ₹2,601.1 23.87 ₹32,553.96 Cr. 0.92 ₹422.01 Cr. 127.54 8.33 2003.49 18.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharmaceuticals Industries Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -1,8242,4082,6813,0172,4732,2612,5523,3093,3733,0142,8362,963
YOY Sales Growth %-10.27%23.51%33.04%68.02%35.61%-6.11%-4.80%9.70%36.39%33.27%11.13%-10.46%
Expenses -1,9071,9362,1452,1622,3052,0871,9942,3672,5382,3082,6082,241
Material Cost %49.35%38.74%32.88%27.67%36.12%43.40%37.77%32.18%36.09%36.67%41.62%35.50%
Employee Cost %21.55%16.84%15.23%12.25%15.55%17.30%16.69%12.89%12.83%14.07%14.79%15.73%
Operating Profit-84472536855169175558942835706229722
OPM %-5%20%20%28%7%8%22%28%25%23%8%24%
Other Income8923317731-6812867919258151,21921
Interest13065111137151133119571149913869
Depreciation105120123156131134132136139144142143
Profit before tax574321479594-795-659867688404781,167532
Tax %-1%0%-5%0%-1%41%-8%1%2%2%1%-0%
Net Profit577321505593-806-391,0687638234691,156532
EPS in Rs2.411.342.102.47-3.36-0.164.453.183.431.954.822.22
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -3,7802,4863,1084,0162,4322,8298,0287,7197,6848,98210,30312,53212,186
Sales Growth %22.44%-34.24%25.03%29.22%-39.43%16.31%183.81%-3.85%-0.46%16.90%14.70%21.63%
Expenses -2,6081,5571,7832,4271,9192,8918,5878,2087,5708,1408,7109,8209,695
Material Cost %50.53%32.80%28.86%26.33%36.85%37.65%43.76%38.78%42.91%39.75%35.65%36.45%
Manufacturing Cost %3.51%5.72%7.28%7.47%16.03%16.24%13.95%15.67%15.84%13.85%12.67%10.01%
Employee Cost %3.92%7.03%8.40%7.88%9.66%9.89%18.53%19.13%19.52%18.09%15.25%13.59%
Other Cost %11.02%17.09%12.84%18.76%16.38%38.42%30.71%32.75%20.24%18.93%20.96%18.31%
Operating Profit1,1729291,3241,588513-62-559-4891148421,5932,7122,491
OPM %31%37%43%40%21%-2%-7%-6%1%9%15%22%20%
Other Income18591194214237-2,6192124455153142201,5111,514
Interest3000018551574224388541408420
Depreciation5969647686102661464422487553562569
Profit before tax1,2959491,4541,726663-2,801-1,559-1,082-172807193,2533,016
Tax %2%5%5%2%22%-1%5%-0%-36%-9%-14%1%
Net Profit1,2658991,3841,697517-2,829-1,474-1,088-233068173,2112,980
EPS in Rs5.884.111.281.570.410.000.000.000.001.273.4013.3812.42
Dividend Payout %23%32%26%26%50%-11%-42%-22%-3,677%157%81%30%

Compounded Sales Growth

  • 10 Years:: 17.56%
  • 5 Years:: 9.31%
  • 3 Years:: 17.71%
  • TTM:: 15.01%

Compounded Profit Growth

  • 10 Years:: 12.46%
  • 5 Years:: 31.47%
  • 3 Years:: 136.71%
  • TTM:: 36.05%

Return on Equity

  • 10 Years:: 11.63%
  • 5 Years:: -10.14%
  • 3 Years:: 2.17%
  • 1 Year:: 15.12%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -104104104104104207207241240240240240
Equity Capital104104104104104207207241240240240240
Reserves5,0485,6146,5777,7757,6857,20122,53121,64920,77322,08322,60424,156
Borrowings24295140432,4096,8115,8296,0476,8846,4376,406
Other Liabilities -1,0337218761,2131,4144,5487,8976,5486,8107,5858,4347,608
Trade Payables4782242704003633801,5771,7722,0732,5662,1552,335
Advance from Customers102810600104283540279436
Other liability items5444695968071,0524,1676,2174,7484,7034,9796,0004,837
Total Liabilities6,2086,4697,6079,1319,24614,36437,44634,26633,86936,79237,71438,410
Fixed Assets -6997417949771,1361,2673,1853,5754,0394,6454,9785,229
Gross Block1,0621,1601,2691,4831,7251,9745,9954,1044,9886,5737,4618,245
Accumulated Depreciation3614164745065897062,8105299491,9282,4833,016
CWIP76921962493484801,0917681,100988643597
Investments2,6954,0523,6014,4384,3187,01625,87622,37219,33318,35517,90417,362
Other Assets -2,7381,5843,0153,4673,4455,6017,2947,5529,39712,80414,18915,223
Inventories4875706186408699182,1892,1322,3082,1362,7932,634
Trade receivables6805535437137389801,8031,9982,7155,2715,0316,168
Cash Equivalents1,265891,2511,328431141416169170155341655
Loans n Advances3113824664519182,8111,3371,6951,9072,7204,1843,794
Other asset items-6-101373354907501,5481,5582,2972,5221,8401,973
Total Assets6,2086,4697,6079,1319,24614,36437,44634,26633,86936,79237,71438,410

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -1,2626461,2321,339106-2,405149-1,254-1,621-1,1711,2421,306
Profit from operations1,1549761,3401,838589-2,758-973-317-68-151,1683,036
Receivables3611119-294-28-187277-305-668-539170-922
Inventory-97-83-48-168-229-5042457-167173-657159
Payables-156-308-34128-361711917632711-40194
Loans Advances0041-49-64-93-5200000
Other WC items0002943815547-513-261-5101,000-724
Working capital changes108-281-32-354-3145021,315-585-769-865112-1,393
Direct taxes1-49-74-144-169-149-193-353-784-291-37-337
Exceptional CF items00-2000000000
Cash from Investing Activity --660-159-1,073-7714565172,6423,6402,3811,3944311,483
Fixed assets purchased-174-127-245-388-430-434-1,028-564-1,094-746-597-572
Fixed assets sold5513121514106126
Investments purchased-6,295-16,934-12,294-13,466-15,363-19,454-10,360-13,197-17,639-16,806-17,098-14,866
Investments sold5,68315,69212,63513,18414,77320,19112,19113,25217,65116,83416,88314,786
Interest received8413811414520810689551714411928
Dividends received0000000392048154761,350
Invest in subsidiaries00-0-381-1,316-616-000000
Loans to subsidiaries00000000-0000
Shares acq cancelled00000003,8473,2321,290970870
Acquisition of companies0000000-16-1-86-293-151
Inter corporate deposits36-1110000000000
Other investing items01,178-1,2831322,5837231,7362090-58-4331
Cash from Financing Activity --326-327-312-420-5091,742-2,674-2,368-753-272-1,469-2,871
Proceeds from shares0000007592100
Proceeds from borrowings1621000000017,12210,554
Repayment of borrowings0000000000-17,843-11,267
Interest paid fin-5-0-1-0-0-18-332-364-144-284-268-155
Dividends paid-207-284-285-352-440-518-310-722-240-798-480-1,379
Other financing items-115-48-47-67-692,278-2,106-1,291-372809-1-624
Net Cash Flow276160-15314853-145117177-50205-82

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %27%18%23%25%8%0%-6%-3%-0%5%8%11%
Debtor Days668164651111268294129214178180
Inventory Turnover4.471.631.591.791.311.322.511.561.641.781.661.83

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharmaceuticals Industries Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.